Compare PKX & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKX | PHG |
|---|---|---|
| Founded | 1968 | 1891 |
| Country | South Korea | Netherlands |
| Employees | N/A | 64317 |
| Industry | Steel/Iron Ore | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.1B | 26.5B |
| IPO Year | 1998 | N/A |
| Metric | PKX | PHG |
|---|---|---|
| Price | $53.24 | $26.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 338.9K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | 1.36% | ★ 3.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.61 | $2.93 |
| Revenue Next Year | $3.56 | $4.49 |
| P/E Ratio | $42.95 | ★ $28.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.99 | $23.85 |
| 52 Week High | $92.40 | $33.44 |
| Indicator | PKX | PHG |
|---|---|---|
| Relative Strength Index (RSI) | 48.81 | 46.23 |
| Support Level | $50.73 | $25.89 |
| Resistance Level | $55.23 | $27.50 |
| Average True Range (ATR) | 1.30 | 0.71 |
| MACD | 0.74 | -0.08 |
| Stochastic Oscillator | 78.20 | 65.47 |
POSCO Holdings Inc is a holding company operating through its subsidiaries. Its business is divided into segments, with the Steel segment generating the majority of revenue from the manufacture and sale of steel products. The Infrastructure segment includes trading, construction, and logistics and system integration activities. The Rechargeable Battery Materials segment focuses on EV battery materials such as lithium, nickel, and cathode and anode materials. The Others segment includes the controlling company and investment business. Geographically, the Group generates majority of its revenue from Asia (excluding China and Japan).
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.